|
Originally published In Press as doi:10.1074/jbc.M804282200 on July 23, 2008
J. Biol. Chem., Vol. 283, Issue 40, 27208-27219, October 3, 2008
GLUT4 Vesicle Recruitment and Fusion Are Differentially Regulated by Rac, AS160, and Rab8A in Muscle Cells*
Varinder K. Randhawa 1,
Shuhei Ishikura 2,
Ilana Talior-Volodarsky 2,
Alex W. P. Cheng 3,
Nish Patel 4,
John H. Hartwig¶, and
Amira Klip 5
From the
Program in Cell Biology, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada, Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada, and ¶Division of Hematology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Insulin increases glucose uptake into muscle by enhancing the surface recycling of GLUT4 transporters. In myoblasts, insulin signals bifurcate downstream of phosphatidylinositol 3-kinase into separate Akt and Rac/actin arms. Akt-mediated Rab-GAP AS160 phosphorylation and Rac/actin are required for net insulin gain of GLUT4, but the specific steps (vesicle recruitment, docking or fusion) regulated by Rac, actin dynamics, and AS160 target Rab8A are unknown. In L6 myoblasts expressing GLUT4myc, blocking vesicle fusion by tetanus toxin cleavage of VAMP2 impeded GLUT4myc membrane insertion without diminishing its build-up at the cell periphery. Conversely, actin disruption by dominant negative Rac or Latrunculin B abolished insulin-induced surface and submembrane GLUT4myc accumulation. Expression of non-phosphorylatable AS160 (AS160-4P) abrogated membrane insertion of GLUT4myc and partially reduced its cortical build-up, an effect magnified by selective Rab8A knockdown. We propose that insulin-induced actin dynamics participates in GLUT4myc vesicle retention beneath the membrane, whereas AS160 phosphorylation is essential for GLUT4myc vesicle-membrane docking/fusion and also contributes to GLUT4myc cortical availability through Rab8A.
Received for publication, June 3, 2008
, and in revised form, July 17, 2008.
* This study was supported by Grant MOP-7307 (to A. K.) from the Canadian Institutes of Health Research (CIHR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S4.
1 Supported by doctoral awards from CIHR, Banting and Best Diabetes Centre (BBDC)-Novo Nordisk-University of Toronto, and an Ontario Graduate Scholarship; recipient of the Joe Connolly Award.
2 Supported by fellowships from BBDC and the Hospital for Sick Children.
3 Supported by a BBDC studentship.
4 Supported by a CIHR doctoral award.
5 To whom correspondence should be addressed: Program in Cell Biology, Hospital for Sick Children, 555 University Ave., Toronto, ON M5G 1X8, Canada. Tel.: 416-813-6392; Fax: 416-813-5028; E-mail: amira{at}sickkids.ca.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. B. Jorgensen, J. Honeyman, J. S. Oakhill, D. Fazakerley, J. Stockli, B. E. Kemp, and G. R. Steinberg
Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation
Am J Physiol Endocrinol Metab,
July 1, 2009;
297(1):
E57 - E66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Funai, G. G. Schweitzer, N. Sharma, M. Kanzaki, and G. D. Cartee
Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle
Am J Physiol Endocrinol Metab,
July 1, 2009;
297(1):
E242 - E251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kachko, A. Maissel, L. Mazor, R. Ben-Romano, R. T. Watson, J. C. Hou, J. E. Pessin, N. Bashan, and A. Rudich
Postreceptoral Adipocyte Insulin Resistance Induced by Nelfinavir Is Caused by Insensitivity of PKB/Akt to Phosphatidylinositol-3,4,5-Trisphosphate
Endocrinology,
June 1, 2009;
150(6):
2618 - 2626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Linder, M. I. Mayranpaa, J. Peranen, T. E. Pietila, V. M. Pietiainen, R.-L. Uronen, V. M. Olkkonen, P. T. Kovanen, and E. Ikonen
Rab8 Regulates ABCA1 Cell Surface Expression and Facilitates Cholesterol Efflux in Primary Human Macrophages
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2009;
29(6):
883 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|